Hims & Hers CEO Responds to FTC Lawsuit
Hims & Hers CEO Andrew Dudum explains his company's work as the FTC looks into how it operates.
Andrew Dudum leads Hims & Hers. He spoke with CNBC about the recent attention from the Federal Trade Commission. The FTC has concerns about how some companies sell healthcare products online. Mr. Dudum believes the FTC does not fully understand how Hims & Hers helps patients.
The company offers compounded GLP-1 drugs. These are medicines that help with weight loss. Hims & Hers also uses artificial intelligence to improve care. The CEO says these tools make healthcare easier and more affordable for many people.
Mr. Dudum's message is clear. He wants to show that Hims & Hers follows the rules. The company aims to make health services simple and safe. This means customers can get care they need without difficulty.
Source: CNBC
More from Biotech
